TD Cowen Maintains Buy on Alamar Biosciences, Raises Price Target to $36
Benzinga Newsdesk 8 hours ago
Analyst RatingsNewsPrice Target
TD Cowen analyst Dan Brennan maintains Alamar Biosciences (NASDAQ:ALMR) with a Buy and raises the price target from $34 to $36.
TD Cowen analyst Dan Brennan maintains Alamar Biosciences (NASDAQ:ALMR) with a Buy and raises the price target from $34 to $36.